These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 17224333

  • 1. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH.
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [Abstract] [Full Text] [Related]

  • 2. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S, Adachi H, Nakamura K, Matsui T, Jinnouchi Y, Takenaka K, Takeuchi M, Enomoto M, Furuki K, Hino A, Shigeto Y, Imaizumi T.
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [Abstract] [Full Text] [Related]

  • 3. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK, Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Hyun YJ, Cho JR, Lee JH.
    Clin Chim Acta; 2007 May 01; 380(1-2):68-74. PubMed ID: 17335789
    [Abstract] [Full Text] [Related]

  • 4. The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin.
    Jang Y, Lee JH, Kim OY, Koh SJ, Chae JS, Woo JH, Cho H, Lee JE, Ordovas JM.
    Metabolism; 2006 Jan 01; 55(1):59-66. PubMed ID: 16324920
    [Abstract] [Full Text] [Related]

  • 5. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K, Somoza V, Jarcusková M, Heidland A, Podracká L.
    Int J Pediatr Obes; 2009 Jan 01; 4(2):112-8. PubMed ID: 18645732
    [Abstract] [Full Text] [Related]

  • 6. Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers.
    Boor P, Celec P, Klenovicsová K, Vlková B, Szemes T, Minárik G, Turna J, Sebeková K.
    Clin Chim Acta; 2010 Aug 05; 411(15-16):1034-40. PubMed ID: 20359471
    [Abstract] [Full Text] [Related]

  • 7. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
    Tesarová P, Kalousová M, Jáchymová M, Mestek O, Petruzelka L, Zima T.
    Cancer Invest; 2007 Dec 05; 25(8):720-5. PubMed ID: 18058469
    [Abstract] [Full Text] [Related]

  • 8. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.
    Catalano M, Cortelazzo A, Santi R, Contino L, Demicheli M, Yilmaz Y, Zorzetto M, Campo I, Lanati N, Emanuele E.
    Clin Biochem; 2008 Aug 05; 41(12):981-5. PubMed ID: 18538667
    [Abstract] [Full Text] [Related]

  • 9. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
    Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL.
    Nutr Metab Cardiovasc Dis; 2009 Feb 05; 19(2):129-34. PubMed ID: 18595673
    [Abstract] [Full Text] [Related]

  • 10. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G.
    Clin Endocrinol (Oxf); 2005 Jan 05; 62(1):37-43. PubMed ID: 15638868
    [Abstract] [Full Text] [Related]

  • 11. Serum advanced glycation end products (AGEs) are associated with insulin resistance.
    Tan KC, Shiu SW, Wong Y, Tam X.
    Diabetes Metab Res Rev; 2011 Jul 05; 27(5):488-92. PubMed ID: 21337488
    [Abstract] [Full Text] [Related]

  • 12. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.
    Diabetes Metab Res Rev; 2008 Feb 05; 24(2):109-14. PubMed ID: 17694504
    [Abstract] [Full Text] [Related]

  • 13. Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness.
    Choi KM, Yoo HJ, Kim HY, Lee KW, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH.
    Int J Cardiol; 2009 Feb 06; 132(1):96-101. PubMed ID: 18190981
    [Abstract] [Full Text] [Related]

  • 14. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
    Däbritz J, Friedrichs F, Weinhage T, Hampe J, Kucharzik T, Lügering A, Broeckel U, Schreiber S, Spieker T, Stoll M, Foell D.
    Am J Physiol Gastrointest Liver Physiol; 2011 May 06; 300(5):G823-32. PubMed ID: 21311028
    [Abstract] [Full Text] [Related]

  • 15. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.
    Peng WH, Lu L, Wang LJ, Yan XX, Chen QJ, Zhang Q, Zhang RY, Shen WF.
    Arch Med Res; 2009 Jul 06; 40(5):393-8. PubMed ID: 19766904
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.
    Microvasc Res; 2008 May 06; 76(1):52-6. PubMed ID: 18474381
    [Abstract] [Full Text] [Related]

  • 17. The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation.
    Gençtoy G, Kahraman S, Arici M, Altun B, Erdem Y, Bakkaloğlu M, Yasavul U, Turgan C.
    Transplant Proc; 2006 Mar 06; 38(2):521-8. PubMed ID: 16549165
    [Abstract] [Full Text] [Related]

  • 18. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
    Gaens KH, Ferreira I, van der Kallen CJ, van Greevenbroek MM, Blaak EE, Feskens EJ, Dekker JM, Nijpels G, Heine RJ, 't Hart LM, de Groot PG, Stehouwer CD, Schalkwijk CG.
    J Clin Endocrinol Metab; 2009 Dec 06; 94(12):5174-80. PubMed ID: 19890027
    [Abstract] [Full Text] [Related]

  • 19. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ, Lin SH, Pei D, Kuo SW, Hsieh CH, He CT, Hsing Lee C, Fan SC, Sheu WH.
    Metabolism; 2006 Apr 06; 55(4):439-44. PubMed ID: 16546473
    [Abstract] [Full Text] [Related]

  • 20. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A.
    Arthritis Res Ther; 2005 Apr 06; 7(4):R817-24. PubMed ID: 15987483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.